Polycythemia vera (PV) is one of the most prevalent myeloproliferative neoplasms (MPNs), identified by the presence of activating somatic mutations in the JAK2 gene and characterized by excessive production of red blood cells, platelets, and neutrophils. Here, JAK2 is linked to acquired polycythemia vera.